Ischemic heart disease Board decisions

The Veteran's claim for an earlier effective date for the 60 percent rating for service-connected ischemic heart disease is denied. The Board found that a factually ascertainable increase in disability was not present within one year prior to December 10, 2019. For the period before November 14, 2021, the Veteran's claim for an increased rating is also denied as there is no evidence of chronic congestive heart failure or a workload of 3.0 METs or less resulting in heart failure symptoms.

The appeals for service connection of various disabilities have been dismissed as the Veteran has withdrawn his appeal. The issue of a total disability rating based on individual unemployability (TDIU) is remanded.

The Board has remanded the case due to inadequate opinions regarding service connection for a heart disorder, specifically PTSD. The examiner is asked to consider and address an article provided by the appellant.

The Veteran's hypertension is rated at 60% from January 19, 2010. The Board denied a higher rating for hypertension and granted TDIU effective from January 19, 2010.,Prior to January 19, 2010, the Veteran did not meet the schedular requirements for TDIU due to his service-connected disabilities.

The Board denied the Veteran's petitions to readjudicate his claims of service connection for thyroid carcinoma, bilateral hearing loss, prostate cancer, ischemic heart disease, and hypertension as no new and relevant evidence was presented.

The Board has remanded the Veteran's claim for service connection for coronary artery disease due to a pre-decisional duty to assist error in the November 2022 medical opinion. Additional opinions are needed regarding obesity as an intermediate step and potential toxic exposure risk activity (TERA).

The Veteran's claim for increased ratings for coronary artery disease (CAD) is remanded due to the failure to obtain a VA medical opinion that addressed the contention regarding two-dimensional diagnostic imaging and its impact on the severity of CAD symptoms.

The Veteran's CAD is rated at 30 percent, effective March 12, 2020. The VA also granted a TDIU from March 12, 2020 to August 20, 2022, and SMC from August 21, 2022.

The Veteran's claims for service connection related to DM, diabetic peripheral neuropathy, diabetic retinopathy, hypertension, and CAD have been granted under the PACT Act. The Veteran was exposed to herbicide agents in Guam.,Service connection has also been established for prostate cancer and Parkinson's Disease.

The Veteran's claim for an earlier effective date for a TDIU rating is denied as there was no pending unadjudicated claim at the time of his May 2019 increased rating claim for PTSD.

The Veteran withdrew his appeal regarding service connection for a heart disability and obstructive sleep apnea, leading to the dismissal of these claims.

The Veteran's death records suggest a potential cardiovascular disorder, but no specific diagnosis was made. The PACT Act requires VA to obtain an opinion regarding the etiology of any such disorders due to service-connected toxic exposure.

The Veteran's claim for an earlier effective date for a TDIU rating is denied as there was no pending unadjudicated claim at the time of his May 2019 increased rating claim for PTSD.

The Veteran's claim for an increased rating of 60 percent for ischemic heart disease is granted, as his left ventricle ejection fraction was 50%, which meets the criteria for a 60% rating under the pre-amended criteria. However, he does not meet the criteria for a higher rating due to lack of congestive heart failure symptoms.

The Veteran's ischemic heart disease with congestive heart failure and valvular heart disease is granted as due to herbicide agent exposure during service.

The Veteran's CAD was rated at a higher than 30 percent rating from October 5, 2007 to August 25, 2008. The VA found the Veteran met the criteria for a 60 percent rating based on his LVEF of 50 percent.

The Board has remanded the claims for service connection for glaucoma, Parkinson's disease, and dementia due to potential TERA exposure. The rating for bilateral hearing loss is also being remanded.

The Veteran's claims for service connection have been granted, but the effective dates are not established. The application to revise a March 1995 rating decision based on CUE is denied.

The Board has decided to remand the claim for a heart disorder, including arteriosclerotic heart disease and coronary artery disease, due to inadequate VA examination opinions and potential exposure to toxins during service.

The Veteran's claim for an earlier effective date for service-connected coronary artery disease is granted, with the earliest effective date being December 29, 2021. The condition was established based on presumed exposure to herbicides during service at Korat RTAFB in Thailand.